Pulse Biosciences Inc
PLSE14.880USD
+0.130+0.88%
Market hours （ET）Quotes delayed by 15 min
1.00BMarket Cap
LossP/E TTM
More Details of Pulse Biosciences Inc Company
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Company Info
Ticker SymbolPLSE
Company namePulse Biosciences Inc
IPO dateMay 18, 2016
CEOMr. Paul A. Laviolette
Number of employees75
Security typeOrdinary Share
Fiscal year-endMay 18
Address3957 Point Eden Way
CityHAYWARD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94545
Phone15109064600
Websitehttps://www.pulsebiosciences.com/
Ticker SymbolPLSE
IPO dateMay 18, 2016
CEOMr. Paul A. Laviolette
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Robert William (Bob) Duggan
Mr. Robert William (Bob) Duggan
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
48.60M
--
Dr. Mahkam (Maky) Zanganeh
Dr. Mahkam (Maky) Zanganeh
Independent Director
Independent Director
873.47K
--
Mr. Darrin R. Uecker
Mr. Darrin R. Uecker
Chief Technology Officer, Director
Chief Technology Officer, Director
122.87K
-19.62%
Mr. Jon Skinner
Mr. Jon Skinner
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Mr. Kevin P. Danahy
Mr. Kevin P. Danahy
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Mitchell E. Levinson
Mr. Mitchell E. Levinson
Chief Strategy Officer
Chief Strategy Officer
--
--
Mr. Paul A. Laviolette
Mr. Paul A. Laviolette
Co-Chairman of the Board, President, Chief Executive Officer
Co-Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Manmeet S. Soni, CPA
Mr. Manmeet S. Soni, CPA
Lead Independent Director
Lead Independent Director
--
--
Mr. Richard A. (Rich) van Den Broek
Mr. Richard A. (Rich) van Den Broek
Independent Director
Independent Director
--
--
Mr. Steven T. Weber
Mr. Steven T. Weber
Vice President of Accounting and Global Corporate Controller, Principal Accounting Officer
Vice President of Accounting and Global Corporate Controller, Principal Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Robert William (Bob) Duggan
Mr. Robert William (Bob) Duggan
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
48.60M
--
Dr. Mahkam (Maky) Zanganeh
Dr. Mahkam (Maky) Zanganeh
Independent Director
Independent Director
873.47K
--
Mr. Darrin R. Uecker
Mr. Darrin R. Uecker
Chief Technology Officer, Director
Chief Technology Officer, Director
122.87K
-19.62%
Mr. Jon Skinner
Mr. Jon Skinner
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Mr. Kevin P. Danahy
Mr. Kevin P. Danahy
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Mitchell E. Levinson
Mr. Mitchell E. Levinson
Chief Strategy Officer
Chief Strategy Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Systems
0.00
0.00%
Cycle units
0.00
0.00%
By RegionUSD
Name
Revenue
Proportion
North America
0.00
0.00%
Rest of World
0.00
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Systems
0.00
0.00%
Cycle units
0.00
0.00%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Duggan (Robert William)
72.24%
BlackRock Institutional Trust Company, N.A.
1.81%
Zanganeh (Mahkam)
1.30%
The Vanguard Group, Inc.
1.25%
BofA Global Research (US)
1.16%
Other
22.26%
Shareholders
Shareholders
Proportion
Duggan (Robert William)
72.24%
BlackRock Institutional Trust Company, N.A.
1.81%
Zanganeh (Mahkam)
1.30%
The Vanguard Group, Inc.
1.25%
BofA Global Research (US)
1.16%
Other
22.26%
Shareholder Types
Shareholders
Proportion
Individual Investor
73.97%
Investment Advisor
4.38%
Investment Advisor/Hedge Fund
2.36%
Research Firm
1.32%
Hedge Fund
0.37%
Pension Fund
0.11%
Bank and Trust
0.06%
Sovereign Wealth Fund
0.03%
Other
17.39%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
170
55.58M
82.63%
-454.44K
2025Q1
171
55.60M
82.67%
-380.27K
2024Q4
161
55.79M
90.70%
+5.71M
2024Q3
153
49.96M
81.56%
+5.91M
2024Q2
136
43.75M
79.18%
-238.05K
2024Q1
135
43.68M
79.09%
-52.16K
2023Q4
133
43.32M
78.65%
+197.90K
2023Q3
133
41.46M
75.60%
-827.09K
2023Q2
134
41.10M
75.12%
+5.77M
2023Q1
139
24.09M
64.12%
-1.58M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Duggan (Robert William)
48.60M
72.24%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.21M
1.81%
-25.91K
-2.09%
Mar 31, 2025
Zanganeh (Mahkam)
873.47K
1.3%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
839.06K
1.25%
-303.29K
-26.55%
Mar 31, 2025
BofA Global Research (US)
777.76K
1.16%
-10.69K
-1.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
465.72K
0.69%
+4.95K
+1.07%
Mar 31, 2025
State Street Global Advisors (US)
419.24K
0.62%
-55.01K
-11.60%
Mar 31, 2025
Griffin Asset Management, Inc.
233.56K
0.35%
-3.99K
-1.68%
Mar 31, 2025
Northern Trust Investments, Inc.
200.07K
0.3%
-8.66K
-4.15%
Mar 31, 2025
Charles Schwab Investment Management, Inc.
149.64K
0.22%
+433.00
+0.29%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Inspire Small/Mid Cap ESG ETF
0.18%
Vanguard US Momentum Factor ETF
0.1%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
iShares Morningstar Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
View more
Inspire Small/Mid Cap ESG ETF
Proportion0.18%
Vanguard US Momentum Factor ETF
Proportion0.1%
iShares Micro-Cap ETF
Proportion0.06%
iShares Russell 2000 Growth ETF
Proportion0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
iShares Morningstar Small-Cap ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
